サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1666173

貯血式自己血輸血の世界市場：2025年～2033年

Global Stored Autologous Blood Transfusion Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
貯血式自己血輸血の世界市場：2025年～2033年
出版日: 2025年02月24日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の貯血式自己血輸血市場は、2024年に1,498億米ドルに達し、2033年には1,823億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは2.5%で成長します。

手術件数の増加とハイリスク手術の増加は、貯血式自己血輸血市場の成長を大きく促進しており、安全で効率的な血液管理システムに対する需要を増加させることで、予測期間中も市場を牽引すると予想されます。リスクの高い手術では大量の出血を伴うことが多く、自己血輸血は同種血輸血よりも安全で信頼性の高い代替手段と考えられています。

大量出血が一般的な脊椎手術では、自己貯血を使用することが好ましいです。なぜなら、自己貯血を使用すれば、輸血に関連した感染症や免疫学的反応のリスクが排除されるからです。

例えば、米国国立衛生研究所（NIH）によると、世界の推定では、年間3億1,300万件近くの手術が行われており、米国では毎年約50万件の腰椎手術が行われています。脊椎手術患者の最大80％が術後に不快感を経験し、20％が術後に持続的な痛みを経験します。アメリカでは年間約90万人、カナダでは年間約3万人の成人が脊椎手術を受けています。このような脊椎手術の増加は、過剰な出血のリスクを高める可能性があり、手術前に貯血し、そのような手術のために患者の血液を輸血するための貯血式自己血輸血装置の需要をさらに押し上げます。

当レポートでは、世界の貯血式自己血輸血市場について調査し、市場の概要とともに、製品タイプ別、用途別、貯血期間別、技術別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析

第5章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 製品タイプ別

  • 血液採取装置
  • 輸血キット
  • 血液処理製品
  • 貯血装置

第7章 用途別

  • 整形外科手術
  • 一般外科
  • 産婦人科手術
  • その他

第8章 貯血期間別

  • 短期保管
  • 長期保管

第9章 技術別

  • 手動採血
  • 自動採血

第10章 エンドユーザー別

  • 血液バンク
  • 病院
  • 外来手術センター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第12章 競合情勢

第13章 企業プロファイル

  • Terumo Corporation
  • Haemonetics Corporation
  • Medtronic
  • JMS Co. Ltd.
  • Narang Medical Limited.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Nipro
  • Macopharma
  • Cardinal Health

第14章 付録

目次
Product Code: MD9190

The global stored autologous blood transfusion market reached US$ 149.8 billion in 2024 and is expected to reach US$ 182.3 billion by 2033, growing at a CAGR of 2.5% during the forecast period 2025-2033.

Stored autologous blood transfusion refers to the process in which a patient donates their blood before a scheduled surgery or medical procedure, and this blood is then stored for future use during or after the procedure if needed. The key characteristic of autologous transfusion is that the donor and the recipient are the same individual. This eliminates the risks associated with allogeneic (donor) blood transfusions, such as transfusion reactions, infections, and immune complications.

The patient donates blood several days or weeks before planned surgery, typically in a hospital or clinical setting, the collected blood is processed and stored in blood banks, where it is preserved using anticoagulants to maintain its viability if needed, the stored blood is retrieved and reinfused into the patient during surgery or recovery, this is typically used to manage blood loss during the procedure if the patient experiences excessive blood loss after surgery, the stored blood can be reinfused to replenish lost blood volumes and improve recovery outcomes. Stored autologous blood can alleviate reliance on external blood donors, particularly in surgeries where blood loss is anticipated.

Market Dynamics: Drivers & Restraints

Growth in Surgical Volume and High-Risk Procedures

The growth in surgical volume and high-risk procedures is significantly driving the growth of the stored autologous blood transfusion market and is expected to drive the market over the forecast period by increasing the demand for safe and efficient blood management systems. High-risk surgeries often involve significant blood loss and autologous blood transfusion is considered a safer and more reliable alternative to allogeneic blood transfusions.

In spinal surgeries where large blood losses are common, using stored autologous blood is preferred because it eliminates the risk of transfusion-related infections and immunological reactions, which can be life-threatening in high-risk patients.

For instance, according to the National Institute of Health (NIH), global estimates suggest that close to 313 million surgeries are performed annually with approximately 500,000 lumbar spine surgeries each year in the United States. Up to 80% of spine surgery patients experience post-surgery discomfort and 20% will experience persistent post-surgical pain. Approximately 900,000 American and 30,000 Canadian adults undergo spine surgery annually. These rising spinal surgeries may increase the risk of excessive blood loss, which further boosts the demand for stored autologous blood transfusion devices to store the blood before surgery and to transfuse the patient's blood for such surgery.

Limited Applicability in Certain Surgeries

Limited applicability in certain surgeries is expected to hamper the growth of the stored autologous blood transfusion market. While autologous blood transfusion is highly beneficial in many high-risk surgeries, it is not suitable or practical in all types of surgeries. Several factors contribute to its limited applicability, and this restricts the market's growth potential.

Segment Analysis

The global stored autologous blood transfusion market is segmented based on product type, application, storage duration, technology, end-user, and region.

Product Type:

Blood collection devices segment is expected to dominate the global stored autologous blood transfusion market share

Blood collection devices are medical tools used in healthcare settings like hospitals, diagnostic laboratories, and blood donation centers for safe and efficient collection, storage, and transportation of blood samples. These devices, including syringes, vacuum-based tubes, capillary systems, lancets, needles, and blood bags, ensure minimal discomfort for patients, prevent contamination, and maintain sample integrity for accurate diagnostic testing or transfusion purposes.

The blood collection devices segment is driving the global stored autologous blood transfusion market due to the significant product launches, demand for safe and efficient methods, technological advancements, and minimally invasive procedures. Moreover, the rise in surgeries requiring autologous blood transfusions and increased awareness about allogeneic blood transfusion risks have increased the need for advanced devices further fueling this segment's growth.

For instance, in March 2024, BD has launched the BD Vacutainer UltraTouch Push Button Blood Collection Set in India to reduce patient pain and discomfort during blood collection. The set uses BD RightGauge technology, a thinner needle, and BD PentaPoint Technology, resulting in a significant decrease in insertion pain. The BD Push Button Technology reduces needle injury chances by 88%. The set is designed to minimize the need for needles during blood collection.

Moreover, in October 2024, Ahlstrom launched Lipid Saver, a new solution for collecting, transporting, and storing fatty acids from whole blood samples. The innovative specimen collection card allows for easy, reliable, and long-term preservation of saturated and unsaturated fatty acids at room temperature.

Geographical Analysis

North America is expected to hold a significant position in the global stored autologous blood transfusion market share

North America dominates the global stored autologous blood transfusion market due to high surgical volumes. The increased awareness of transfusion-related risks, regulatory frameworks in the US, technological advancements in blood collection and storage devices, and leading market players contribute to North America's dominance.

Furthermore, the launch of new products and advancements in the region help the region to grow during the forecast period. For instance, in October 2024, Terumo Blood and Cell Technologies (Terumo BCT) has introduced the Reveos Automated Blood Processing System in the US, aiming to streamline the whole blood processing process and improve efficiency. The system will be used by Carter BloodCare in Texas to manufacture platelets, red blood cells, and plasma for transfusion.

Moreover, according to the Leukemia & Lymphoma Society, about every 3 minutes, a person in the US is diagnosed with either leukemia, lymphoma, or myeloma. In the year 2024, the overall projected case of leukemia, lymphoma, or myeloma in the US is 187,740. New incidences of leukemia, lymphoma and myeloma cases will represent 9.4% of the new cancer cases projected for diagnosis in the US in the year 2024 which will be 2,001,140 cases. Thus, the above factors contribute to the region's dominance in the global market.

Competitive Landscape

The major global players in the stored autologous blood transfusion market include Terumo Corporation, Haemonetics Corporation, Medtronic, JMS Co. Ltd., Narang Medical Limited., Becton, Dickinson and Company, Fresenius Kabi AG, Nipro, Macopharma and Cardinal Health among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Stored Autologous Blood Transfusion Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Storage Duration
  • 3.4. Snippet by Technology
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growth in Surgical Volume and High-Risk Procedures
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Applicability in Certain Surgeries
    • 4.1.3. Opportunity
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Blood Collection Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Blood Transfusion Kits
  • 6.4. Blood Processing Products
  • 6.5. Blood Storage Devices

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Orthopedic Surgeries*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. General Surgeries
  • 7.4. Obstetrics & Gynecology Surgeries
  • 7.5. Others

8. By Storage Duration

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 8.1.2. Market Attractiveness Index, By Storage Duration
  • 8.2. Short-Term Storage*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Long-Term Storage

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Manual Blood Collection*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Automated Blood Collection

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Blood Banks*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Hospitals
  • 10.4. Ambulatory Surgical Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Terumo Corporation*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Haemonetics Corporation
  • 13.3. Medtronic
  • 13.4. JMS Co. Ltd.
  • 13.5. Narang Medical Limited.
  • 13.6. Becton, Dickinson and Company
  • 13.7. Fresenius Kabi AG
  • 13.8. Nipro
  • 13.9. Macopharma
  • 13.10. Cardinal Health
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us